FindTrial
Sign In

prednisone alone

DRUG3 trials

Sponsors

University of Alabama at Birmingham, Guangdong Provincial People's Hospital

Conditions

IgA NephropathyMyasthenia Gravis

Phase 3

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
CompletedNCT00294658
University of Alabama at BirminghamMyasthenia Gravis
Start: 2006-06-30End: 2015-12-31Updated: 2017-05-23

Phase 4

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
NCT01758120
Guangdong Provincial People's HospitalIgA Nephropathy
Start: 2012-12-31End: 2019-12-31Updated: 2017-07-14
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
NCT03218852
Guangdong Provincial People's HospitalIgA Nephropathy
Start: 2016-12-31End: 2021-12-31Updated: 2017-07-17

Related Papers

Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis
Therapeutic Advances in Neurological Disorders2024-08-01
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
2020-07-0117 citations
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
2019-01-25137 citations
Randomized Trial of Thymectomy in Myasthenia Gravis
New England Journal of Medicine2016-08-10873 citations